Glaukos Announces Participation in Piper Jaffray Healthcare Conference

SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced that its management is scheduled to participate in the 28th Annual Piper Jaffray Healthcare Conference on Wednesday, November 30, 2016, at 12:00 p.m. EST in New York City. A live audio webcast for this event will be available in th

Full Story →